Keyphrases
Alzheimer's Disease
33%
Alzheimer's Disease Brain
11%
Alzheimer's Disease Pathology
11%
Amyloid Plaques
11%
Astrocytes
11%
Cerebrospinal Fluid
55%
Cerebrospinal Fluid Biomarkers
11%
Clinical Dementia Rating
66%
Clinical Trial Design
11%
Cognitive Impairment
11%
Control Subjects
11%
Dementia
11%
Dementia Onset
11%
Dementia Progression
11%
Disease Pattern
11%
Disease-associated
11%
Disease-modifying Therapy
11%
Enzyme-linked Immunosorbent Assay (ELISA)
11%
Fluid Biomarkers
100%
Fluid Level
11%
Frontotemporal Lobar Degeneration
11%
Immunohistochemistry
11%
Immunoreactivity
11%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
11%
Mild Alzheimer's Disease
11%
Neuroinflammation
11%
Neuroinflammatory Response
11%
Neuronal Loss
11%
Patient Care
11%
Phosphorylated tau
11%
Plasma Samples
11%
Preclinical Stage
11%
Prognostic Utility
11%
Progressive Supranuclear Palsy
33%
Risk Prediction
11%
Sporadic Alzheimer's Disease
100%
Two-dimensional Difference Gel Electrophoresis
11%
Validation Cohort
22%
YKL-40
100%
Medicine and Dentistry
Alzheimer's Disease
100%
Amyloid Plaque
12%
Astrocyte
12%
Biological Marker
100%
Cerebrospinal Fluid
75%
Clinical Dementia Rating
75%
Clinical Trial Design
12%
Cognitive Defect
12%
Disease Modifying Therapy
12%
Enzyme Linked Immunosorbent Assay
12%
Frontotemporal Lobar Degeneration
12%
Immunohistochemistry
12%
Immunoreactivity
12%
Liquid Chromatography-Mass Spectrometry
12%
Neuroinflammation
12%
Patient Care
12%
Progressive Supranuclear Palsy
37%
Tau
25%
Two Dimensional Difference Gel Electrophoresis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Amyloid Plaque
12%
Biological Marker
100%
Clinical Trial Design
12%
Cognitive Defect
12%
Difference Gel Electrophoresis
12%
Diseases
12%
Enzyme-Linked Immunosorbent Assay
12%
Nervous System Inflammation
12%
Progressive Supranuclear Palsy
37%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
12%
Astrocyte
12%
Blood Plasma
25%
Clinical Dementia Rating
75%
Cognitive Disorders
12%
Difference Gel Electrophoresis
12%
Immunohistochemistry
12%
Liquid Chromatography-Mass Spectrometry
12%
Progressive Supranuclear Palsy
37%